BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang F, Gao J. Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy. World J Gastroenterol 2020; 26(7): 749-758 [PMID: 32116422 DOI: 10.3748/wjg.v26.i7.749]
URL: https://www.wjgnet.com/1007-9327/full/v26/i7/749.htm
Number Citing Articles
1
南秋 刘. Progress on Factors Affecting the Recurrence and Prognosis of Hepatocellular Carcinoma after ResectionAdvances in Clinical Medicine 2022; 12(03): 1663 doi: 10.12677/ACM.2022.123239
2
YouShun Liu, Cong Cheng, HuaBang Zhou, ShouZi Hu, Hao Wang, QiaoHua Xie, LiPing Lei, Peng Wang, GuoFang Liu, HePing Hu. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial ChemoembolizationBulletin du Cancer 2021; 108(10): 931 doi: 10.1016/j.bulcan.2021.04.017
3
Qing Pang, Shuai Zhou, Shuangchi Liu, Huichun Liu, Zheng Lu. Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: a systematic review and meta-analysisUpdates in Surgery 2022; 74(3): 821 doi: 10.1007/s13304-021-01080-w
4
Ziwei Guo, Jun Liang. Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 869 doi: 10.2147/JHC.S360871
5
Ou Ying Yan, Hai Bo Teng, Sheng Nan Fu, Yan Zhu Chen, Feng Liu. Temporal Muscle Thickness is an Independent Prognostic Biomarker in Patients with Glioma: Analysis of 261 CasesCancer Management and Research 2021; : 6621 doi: 10.2147/CMAR.S326232
6
Lining Xu, Weiyu Wang, Yingying Xu. A new risk calculation model for complications of hepatectomy in adults over 75Perioperative Medicine 2024; 13(1) doi: 10.1186/s13741-024-00366-y
7
Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu. Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum BiomarkersDiagnostics 2023; 13(8): 1442 doi: 10.3390/diagnostics13081442
8
Yi Dong Lin, Gui Shu Wu, Ming Yue Rao, Yu Hong Liu, Yun Wei Han, Jing Zhang, Jian Wen Zhang. Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trialScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62523-z
9
Lei Zhao, Nijia Chang, Lei Shi, Fengyi Li, Fanglin Meng, Xiaohui Xie, Zhe Xu, Fusheng Wang. Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world studyHeliyon 2022; 8(6): e09538 doi: 10.1016/j.heliyon.2022.e09538
10
Takashi Ishida, Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Joji Kitayama, Naohiro Sata. Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular CarcinomaCancers 2024; 16(11): 2087 doi: 10.3390/cancers16112087
11
Ziyu Xun, Yanyu Wang, Junyu Long, Yiran Li, Xu Yang, Huishan Sun, Haitao Zhao. Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinomaFrontiers in Genetics 2023; 13 doi: 10.3389/fgene.2022.1034979
12
Lining Xu, Yingying Xu, Guiping Li, Bo Yang. Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinomaEuropean Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00896-5